Log in to access the full article.
Using a novel, hand-collected dataset of U.S. life insurance companies during the influenza pandemic of 1918–9, we show that high-exposure life insurers charged higher prices on new policies vis-à-vis less exposed firms. Although the disease surprisingly increased the mortality rates among younger adults, it also increased awareness of the importance of life insurance. We argue that price increases were a crucial risk management tool. Coupled with a surge in demand and coverage, it prevented further financial distress. Although devastating for public health, the influenza pandemic was not too severe for the life insurance industry.